Hyderabad: Pulsus Group plans to set up an AI-based pharma healthcare IT hub at Ameenpur in Sangareddy District of Telangana with an estimated cost of Rs 300 crore and a potential to create around 50,000 jobs.
Announcing this on the inaugural day of the 73rd Indian Pharmaceutical Congress here on Friday, Pulsus Group CEO and Managing Director Dr Srinubabu Gedela said the project will catalyse the healthcare and IT landscape with an estimated 10,000 direct jobs and around 40,000 indirect jobs through supporting industries and services.
The project, which will be located within the IT/TIeS zone in Ameenpur, will use AI innovations to enrich all aspects of the pharmaceutical industry, from Investigation and development to the provision of health services and generate a considerable number of jobs for residents, he said.
“By integrating the most advanced artificial intelligence, our goal is to streamline processes, improve precision in drug development and improve patient outcomesThis puts Telangana at the forefront of Innovation in health care in India,” Gedela said.
Addressing the conclave, Telangana Industries IT Minister D Sridhar Babu said that Pharmaceutical industry Adopting AI and others cutting-edge technologies It should help make medicines and treatments more affordable for patients.
To further boost the prospects of Telangana and Hyderabad as a global pharma capital, Telangana Chief Minister A Revanth Reddy has decided to adopt the decentralized and cluster-based development approach with 9-10 pharmaceutical zones throughout the state to ensure a self-sustaining ecosystem and generate job In rural areas, he said.
More than 12,000 delegates, including pharmacy students, are taking part in the three-day conclave.
